Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 127

Results For "LAC"

1401 News Found

Lincoln Pharma plans to launch Cephalosporin product portfolio soon
Drug Approval | September 21, 2021

Lincoln Pharma plans to launch Cephalosporin product portfolio soon

Cephalosporin is a bactericidal, broad-spectrum, and P-lactam antibiotic originally derived from the fungus Acremonium, which is used to treat bacterial infections such as pneumonia, skin infections, ear infection, strep throat, staph infections, tonsillitis, bronchitis among others


Glenmark receives ANDA approval for treatment of acne
Drug Approval | September 21, 2021

Glenmark receives ANDA approval for treatment of acne

Clindamycin Phosphate Foam, 1% is the generic version of Evoclin Foam, 1%


Novartis’ Kisqali data indicates longest median survival in advanced breast cancer
Drug Approval | September 20, 2021

Novartis’ Kisqali data indicates longest median survival in advanced breast cancer

With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting


Promising prospects for Indian pharma: CLSA
News | September 17, 2021

Promising prospects for Indian pharma: CLSA

CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report


Machine Learning to understand and prevent disease
Digitisation | September 17, 2021

Machine Learning to understand and prevent disease

Barbara Engelhardt moves her computational and statistics lab to Gladstone


Lancet study confirms Johnson & Johnson Ebola vaccine safe
Drug Approval | September 16, 2021

Lancet study confirms Johnson & Johnson Ebola vaccine safe

Data show the vaccine regimen induced neutralising antibody responses in nearly all participating adults and children 21 days after the second dose. Adults receiving booster shots two years after the initial vaccination regimen showed strong immune responses


Jharkhand to set up pharma park
Policy | September 15, 2021

Jharkhand to set up pharma park

The pharma park will be built at an estimated cost of Rs 34.94 crore and will be spread over 50 acres at Chanho close to Ranchi


Serum Institute to supply polio vaccine for India’s universal immunisation plan
Drug Approval | September 15, 2021

Serum Institute to supply polio vaccine for India’s universal immunisation plan

The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry


Innova Medical Group donates GBP 10 million to launch The Pandemic Institute, Liverpool
Sustainability | September 13, 2021

Innova Medical Group donates GBP 10 million to launch The Pandemic Institute, Liverpool

The institute will provide the world’s first unique and comprehensive capability to predict, prevent, respond and to recover from future pandemics


Advanced Enzyme supplements pass clinical trials for efficacy
Biotech | September 13, 2021

Advanced Enzyme supplements pass clinical trials for efficacy

This clinical study demonstrated that the 14-day regimen of ImmunoSEB and ProbioSEB CSC3 resolved post-Covid-19 fatigue symptoms and improved patients' functional status and quality of life